Меню
Набор скоро начнётся NCT07500909

Study of the Role of Top-down Processes in Neuronal Reorganization and Recovery From Sensory Loss: an Exploratory Behavioral and Electroencephalographic Study in Cochlear-supported Deaf Patients

Наблюдательное Deafness, Bilateral

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: neurophysiological assessment, Cognitive, behavioral and quality of life assessment.
Кому может быть актуально
Состояния в реестре: Deafness, Bilateral. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Список центров уточняется — проверьте первичный протокол.
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Обзор

This study posits that central top-down processes (attention, inhibition), marked by alpha oscillations in EEG, play a key role. Understanding the evolution of these neuronal signatures and their link to pre-implantation visual dependence could allow the identification of biomarkers predictive of the success of auditory rehabilitation.

Подробное описание

Profound bilateral deafness leads to sensory deprivation and neuronal reorganization ( visual recruitment of the auditory cortex). Although cochlear implants restore hearing, comprehension performance varies considerably. Peripheral factors explain only 40% of this variance. This study posits that central top-down processes (attention, inhibition), marked by alpha oscillations in EEG, play a key role. Understanding the evolution of these neuronal signatures and their link to pre-implantation visual dependence could allow the identification of biomarkers predictive of the success of auditory rehabilitation.

Вмешательства

  • Другое neurophysiological assessment
    Electroencephalography and eye tracking
  • Поведенческое Cognitive, behavioral and quality of life assessment
    Cognitive anfd behavioral assessment : Speech recognition test in silence (MBAA) and in noise, verbal working memory task with distractors, Trail Making Test and MoCA test. Quality of lige assessment : This questionnaire is a set of scales concerning patients' hearing abilities, experience, and listening skills in different situations. For each question, the patient must answer by choosing a number between 1 (not at all) and 10 (perfectly).

Первичные конечные точки

  • Evolution of oscillatory signatures [Срок оценки: 6 months]
Вторичные конечные точки (5)
  • EEG (alpha) signatures and eye-tracking [Срок оценки: 6 months]
  • Speech recognition performance [Срок оценки: 6 months]
  • alpha modulation and memory/auditory [Срок оценки: 6 months]
  • audiovisual, visual and auditory comparison [Срок оценки: 6 months]
  • SSQ [Срок оценки: 6 months]

Критерии участия

Критерии включения

For cochlear implant patients:

  • Adult patients
  • Profound bilateral hearing loss requiring a first cochlear implant
  • Normal cochlear anatomy (confirmed by preoperative imaging)
  • Full insertion of the cochlear electrode array planned
  • Acceptance of the protocol and signing of the informed consent form
  • Enrollment in a social security or equivalent plan

For young patients with normal hearing:

  • Adult patients aged 18 to 40
  • Normal and symmetrical hearing
  • Acceptance of the protocol and signature of the informed consent form
  • Affiliation with a social security scheme or equivalent

For older patients with normal hearing:

  • Patients over 50 years of age, matched by gender and age (+/- 2 years) with the cochlear implant patient group
  • Normal and symmetrical hearing, with hearing thresholds < 20 dB HL at 2 kHz and < 40 dB HL at 4 kHz
  • Acceptance of the protocol and signature of the informed consent form
  • Affiliation with a social security scheme or equivalent

For experienced cochlear implant recipients:

  • Adult patients.
  • Unilateral cochlear implant activated for 1 year or more.
  • Disyllabic word recognition score at 60 dB in free field of 70% or higher.
  • Acceptance of the protocol and signature of the informed consent form.
  • Affiliation with a social security plan or equivalent.

For severely deaf patients fitted with hearing aids:

  • Adult patients.
  • Severe bilateral hearing loss.
  • Rehabilitation with one or two optimally fitted hearing aids.
  • Acceptance of the protocol and signing of the informed consent form.
  • Enrollment in a social security or equivalent health insurance plan.

Критерии исключения

  • History of associated neurological pathology
  • Etiologies with unfavorable prognoses, such as recurrent chronic otitis media: These conditions are associated with a poor prognosis due to chronic inflammation that can affect the cochlea
  • Duration of profound bilateral deafness exceeding 5 years (worse prognosis)
  • Contraindications to EEG or other neurophysiological examinations within the study (for all groups)
  • Cognitive impairment confirmed by the MOCA test for the cochlear implant patient group and the group of elderly subjects with normal hearing
  • Use of psychotropic medications that may interfere with the results of cognitive or neurological tests
  • History of epilepsy or other major neurological disorders
  • Pregnancy or breastfeeding
  • Participation in another interventional research protocol or one that impacts the criteria studied in this project
  • Individuals under legal guardianship (guardianship, tutorship, curatorship, institutionalized, or under a future protection mandate)

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Модель наблюдения
Другое

Центры проведения

Список центров уточняется — проверьте первичный протокол.

Идентификаторы

NCT: NCT07500909 · RC31/26/0005 · 2026-A00163-48

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗